[Federal Register Volume 59, Number 176 (Tuesday, September 13, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22529]


[[Page Unknown]]

[Federal Register: September 13, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 

Manufacturer of Controlled Substances; Registration

    By Notice dated July 11, 1994, and published in the Federal 
Register on July 19, 1994, (59 FR 36785), Abbott Laboratories, 14th 
Street & Sheridan Road, Attn: Customer Service D-345, North Chicago, 
Illinois 60064, made application to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of Dextropropoxyphene, 
bulk (non-dosage forms) (9273), a basic class of controlled substance 
listed in Schedule II.
    No comments or objections have been received. Therefore, pursuant 
to section 303 of the Comprehensive Drug Abuse Prevention and Control 
Act of 1970 and Title 21, Code of Federal Regulations, Sec. 1301.54(e), 
the Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: August 29, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-22529 Filed 9-12-94; 8:45 am]
BILLING CODE 4410-09-M